Colonics
 
About Me

Colonics resources

Recent Posts
Menu
Calendar
«  September 2014  »
MonTueWedThuFriSatSun
1234567
891011121314
15161718192021
22232425262728
2930 

Friends
    Links


    Entry 1 of 3128
    Last Page | Next Page
    3/10/2012 - Zytiga Prednisone Combo Metastatic Castration-Resistant Prostate Cancer Trial Unblinded
    Posted in Medical News

    A new aside by Janssen quest & Development, LLC informs that they have unblinded the Phase 3 study, COU-AA-302, which shows that Zytiga (abiraterone acetate), when taken beside prednisone, is productive in treating mildly symptomatic or asymptomatic work who are distress from metastatic castration-resistant prostate cancer (CRPC) and have not gone through chemotherapy. as concerned with Zytiga, which was approved by the U.S Food and Drug supervision (FDA) in 2011, William N. Hait, MD, PhD, from Global Head, Janssen R&D commented: "Since its first validate




    roget's ii: the new thesaurusmain entry:acceptance
    part of speech:noun
    definition:favorable regard.
    approbation in the U...

    More: - From the site

    Share |


    Technorati Tags:
    Filed under:

    :: Send to a Friend!

    Share and enjoy
    • Digg
    • del.icio.us
    • DZone
    • Netvouz
    • NewsVine
    • Reddit
    • Slashdot
    • StumbleUpon
    • Technorati
    • YahooMyWeb
     
    portfolio